{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-046891","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2024-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.824478+00:00","generated_at":"2026-06-05T12:47:01.077024+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Cytek Biosciences amends severance plan; CEO gets 12-month base, 24-month on change of control","bullets":["Compensation Committee approved Second Amended and Restated Severance Benefit Plan effective Feb 20, 2024.","Non-CIC termination: CEO receives 12 months base salary + COBRA; other NEOs get 9 months base + COBRA.","CIC termination: CEO receives 24 months base salary + 100% target bonus + 24 months COBRA + full equity vesting.","Other NEOs get 18 months base salary + 100% target bonus + 18 months COBRA + full equity vesting.","Benefits require signed release and compliance with restrictive covenants."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-046891","json":"https://secwatch.observer/filing/0001193125-24-046891.json","markdown":"https://secwatch.observer/filing/0001193125-24-046891.md","text":"https://secwatch.observer/filing/0001193125-24-046891.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312524046891/0001193125-24-046891-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312524046891/d755593d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T12:47:01.077024+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}